TNFRSF1A and RIPK2

  • Number of citations of the paper that reports this interaction (PMID 9642260)
  • 64
  • Data Source:
  • HPRD (in vivo)

TNFRSF1A

RIPK2

Gene Name tumor necrosis factor receptor superfamily, member 1A receptor-interacting serine-threonine kinase 2
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) ( 23648065)
  • Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) ( 23648065)
  • Multiple sclerosis ( 19525953 21833088)
  • Primary biliary cirrhosis ( 21399635)
Protein-Protein Interactions 60 interactors: ADAM17 ATF6 BAG4 BCL10 CASP10 CASP7 CHUK CLIP3 DAPK1 DAXX ERAP1 ERN1 FANCD2 GNB2L1 GRB2 GYS2 HRG HSP90AA1 HSPA8 IKBKB IKBKG JAK1 JAK2 LTA LTB MADD MAGEH1 MAPK1 MOAP1 MYOC NSMAF PIP4K2B PRDX3 PRKCD PSMD2 PTK2 PTPN11 PTPN6 RASSF1 RIPK1 RIPK2 RIPK3 SGTA SRC STAMBP STAT1 SUMO1 SYK TNF TNFRSF25 TNFSF13 TRADD TRAF1 TRAF2 TRAF3 TRAP1 TRPC4AP UBE2I UBQLN1 UCHL1 31 interactors: BCL10 BIRC2 BIRC3 CARD16 CARD6 CASP1 CASP8 CD40 CFLAR CHUK IKBKG IRAK1 KDM3A LRRK2 MAVS NGFR NOD1 NOD2 PELI3 PRMT2 SMAD4 SMURF1 TLR2 TLR4 TNFRSF1A TRAF1 TRAF2 TRAF5 TRAF6 UBE2I XIAP
Entrez ID 7132 8767
HPRD ID 01861 04585
Ensembl ID ENSG00000067182 ENSG00000104312
Uniprot IDs J9PH39 P19438 O43353
PDB IDs 1EXT 1FT4 1ICH 1NCF 1TNR
Enriched GO Terms of Interacting Partners?
Tagcloud ?
casp3  cl  coincided  corpora  cyclic  disaggregation  estrous  extrinsic  fas  fasl  faslg  fos  ifng  ifngamma  jun  lutea  luteal  luteolysis  luteolytic  p4  pgf2alpha  postmortem  pregnancy  proportions  tnfa  tnfr2  viable 
altogether  appealing  approved  arthritis  bowel  conjunction  crohn  diagnostics  drastically  excessive  fda  gefitinib  ibd  ileitis  improves  nod1  nod2  optimization  peptidoglycan  peritonitis  pharmaceuticals  pharmacologic  potently  predicting  productive  rationale  sarcoidosis  sensors  transduces 
Tagcloud (Difference) ?
casp3  cl  coincided  corpora  cyclic  disaggregation  estrous  extrinsic  fas  fasl  faslg  fos  ifng  ifngamma  jun  lutea  luteal  luteolysis  luteolytic  p4  pgf2alpha  postmortem  pregnancy  proportions  tnfa  tnfr2  viable 
altogether  appealing  approved  arthritis  bowel  conjunction  crohn  diagnostics  drastically  excessive  fda  gefitinib  ibd  ileitis  improves  nod1  nod2  optimization  peptidoglycan  peritonitis  pharmaceuticals  pharmacologic  potently  predicting  productive  rationale  sarcoidosis  sensors  transduces 
Tagcloud (Intersection) ?